Endo Bids For Salix; Valeant May Be Thwarted Again
This article was originally published in The Pink Sheet Daily
Executive Summary
Endo confirmed March 11 that it has offered to acquire the GI specialist for $175 per share, trumping Valeant’s $158 per share offer announced in February.